Biotech startups that raised Series A in Washington, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Oisin Biotechnologies | Seattle | Series A | $10.0M | 2025-08-01 |
| Vilya | Seattle | Series A | $21.0M | 2024-06-04 |
| Ryp Labs | Bothell | Series A | $8.1M | 2023-11-22 |
| Ozette Technologies | Seattle | Series A | $26.0M | 2022-07-28 |
4 rows of the CSV in 5 of its 18 columns.
- The 30 biotech startups in Washington, United States whose last round is Series A have raised $1.2B in total.
- 6 of them closed their most recent round in the last 12 months, $215.0M combined.
- The largest of those rounds is BrainChild Bio's $116.0M Series A, dated September 2026.
- The most recent is Strella Biotechnology's $4.2M Series A on 23 October 2026.
- Madrona is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 23 companies (77%).
- 38% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (62% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
1 of 30| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Ryp Labs | Ryp Labs develops and commercializes technologies that reduce food waste. | Biotech | Bothell | Series A | $8.1M | 2023-11-22 | $19.2M | National Science Foundation, BCP Ventures, King Philanthropies | 11 to 50 | 2017 |
Table 1. Biotech startups that raised Series A in Washington, United States: the 1 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 30.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Madrona | Venture capital firm | Seattle, United States | 2 | 7% | ||
| 2 | AbbVie | Corporate venture arm | North Chicago, United States | 1 | 3% | ||
| 3 | Hedgewood | Family office | Toronto, Canada | 1 | 3% | ||
| 4 | Avant Global LLC | Family office | Las Vegas, United States | 1 | 3% | ||
| 5 | KIZOO Technology Capital | Venture capital firm | Karlsruhe, Germany | 1 | 3% | ||
| 6 | Lifeforce Capital | Venture capital firm | San Francisco, United States | 1 | 3% | ||
| 7 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 1 | 3% | ||
| 8 | NVentures | Corporate venture arm | Santa Clara, United States | 1 | 3% | ||
| 9 | Menlo Ventures | Venture capital firm | Menlo Park, United States | 1 | 3% | ||
| 10 | King Philanthropies | Entrepreneurship program | Menlo Park, United States | 1 | 3% | ||
| 11 | BCP Ventures | Venture capital firm | New York, United States | 1 | 3% | ||
| 12 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 1 | 3% | ||
| 13 | M12 - Microsoft's Venture Fund | Corporate venture arm | San Francisco, United States | 1 | 3% | ||
| 14 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 1 | 3% | ||
| 15 | Cercano Management | Private equity firm | Bellevue, United States | 1 | 3% |
Table 2. Biotech startups that raised Series A in Washington, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 23 | 77% | $807.1M |
| Artificial intelligence | 3 | 10% | $48.4M |
| Software | 3 | 10% | $48.4M |
| Hardware | 2 | 7% | $26.0M |
| Commerce | 1 | 3% | $4.4M |
Table 3. Biotech startups that raised Series A in Washington, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 30 | 100% | $15.0M |
Table 4. Biotech startups that raised Series A in Washington, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Seattle | 19 | 63% |
| Kirkland | 3 | 10% |
| Issaquah | 2 | 7% |
| Spokane | 1 | 3% |
| Bothell | 1 | 3% |
| Lynnwood | 1 | 3% |
| Pullman | 1 | 3% |
| Bellevue | 1 | 3% |
| Camas | 1 | 3% |
Table 5. Biotech startups that raised Series A in Washington, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 17% | $4.2M |
| September 2026 | 2 | 33% | $117.5M |
| August 2026 | 1 | 17% | $35.0M |
| June 2026 | 1 | 17% | $46.0M |
| December 2025 | 1 | 17% | $12.3M |
Table 6. Biotech startups that raised Series A in Washington, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 17% | $202.7M |
| 2025 | 5 | 17% | $226.8M |
| 2024 | 1 | 3% | $21.0M |
| 2023 | 2 | 7% | $33.1M |
| 2022 | 5 | 17% | $191.7M |
| 2021 | 3 | 10% | $182.2M |
Table 7. Biotech startups that raised Series A in Washington, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 4 | 14% |
| 2020 to 2022 | 7 | 24% |
| 2015 to 2019 | 11 | 38% |
| 2010 to 2014 | 4 | 14% |
| Before 2010 | 3 | 10% |
Table 8. Biotech startups that raised Series A in Washington, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 28% |
| 11 to 50 | 18 | 62% |
| 51 to 100 | 3 | 10% |
Table 9. Biotech startups that raised Series A in Washington, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Washington, United States. On 16 November 2026 that is 30 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 1 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 30 rows: 2 have no round amount, 0 no city and 4 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Washington, United States whose last round is Series A are on the list?
- 30, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 30 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.